Stimulant Use Disorder

Stimulants affect the brain by increasing dopamine levels in the reward circuit, leading to intense feelings of happiness and reinforcing drug-taking behaviour. Over time, natural dopamine production is reduced, leaving those affected dependent on the substance to feel normal.

A combination of biological, psychological and environmental factors contributes to vulnerability to stimulant abuse. These risk factors vary from person to person and often overlap, increasing the likelihood of developing a stimulant abuse disorder.

Personal & Genetic Factors

The risk of addiction is often influenced by a family history of substance abuse, suggesting a genetic predisposition. Impulsive personality traits and co-occurring mental health conditions such as ADHD, anxiety or depression also increase the risk of developing stimulant dependence.

Environmental Triggers

External pressures, such as demands at school or work, peer influence and a stressful environment, can lead individuals to seek stimulants to enhance performance. In such environments, stimulant abuse is often normalised, especially when productivity and competition are high priorities.

Early Access to Prescription Stimulants

When stimulants such as Adderall or Ritalin are prescribed in adolescence, especially for the treatment of ADHD, the risk of abuse increases, prolonged use at a young age can promote dependence and encourage non-medical use later in life.

Social Isolation or Lack of Support

People who lack strong social or family ties are more likely to abuse stimulants as a means of coping. These drugs are often used to fill emotional gaps, cope with loneliness or to temporarily escape stressful situations.

Various therapies have been used to address the causes and behavioural patterns of stimulant abuse:

• Cognitive Behavioural Therapy ( CBT ): Helps restructure negative thoughts and behaviours.

• Contingency Management (CM): Rewards sobriety with positive reinforcement.

• Motivational Interviewing (MI): Strengthens the willingness to change.

• Relapse Prevention : Builds coping skills for long-term recovery.

Currently, there are no FDA-approved medications to treat stimulant addiction. Some antipsychotics and antidepressants are being used experimentally. In extreme cases, deep brain stimulation has been explored to target the brain circuitry involved in reward and addiction, although this is still a developing field.

Cadabam’s comprehensive rehab programmes are designed to treat the psychological, physical and social aspects of stimulant use disorder. The focus is on long-term recovery through structured and individualised care.

• Structured Detox: A medically supervised process that helps to manage withdrawal safely and comfortably.

• Therapy Programmes: Daily sessions to examine behavioural patterns and develop coping strategies.

• Peer Support Groups: Individuals share experiences and receive encouragement in a community-based setting.

• Family Counselling: Family members are involved in the therapy to rebuild trust and support recovery.